Scientex Berhad Future Growth
Future criteria checks 2/6
Scientex Berhad is forecast to grow earnings and revenue by 8.4% and 6.4% per annum respectively. EPS is expected to grow by 8.4% per annum. Return on equity is forecast to be 14.2% in 3 years.
Key information
8.4%
Earnings growth rate
8.4%
EPS growth rate
| Chemicals earnings growth | 18.3% |
| Revenue growth rate | 6.4% |
| Future return on equity | 14.2% |
| Analyst coverage | Good |
| Last updated | 12 Jul 2024 |
Recent future growth updates
Scientex Berhad Just Recorded A 7.4% Revenue Beat: Here's What Analysts Think
Jun 25
Scientex Berhad Just Beat Revenue By 7.4%: Here's What Analysts Think Will Happen Next
Mar 28Recent updates
Scientex Berhad (KLSE:SCIENTX) Ticks All The Boxes When It Comes To Earnings Growth
Aug 06Scientex Berhad Just Recorded A 7.4% Revenue Beat: Here's What Analysts Think
Jun 25Scientex Berhad (KLSE:SCIENTX) Is Increasing Its Dividend To MYR0.06
Jun 24Scientex Berhad Just Beat Revenue By 7.4%: Here's What Analysts Think Will Happen Next
Mar 28Here's Why Scientex Berhad (KLSE:SCIENTX) Has Caught The Eye Of Investors
Mar 27An Intrinsic Calculation For Scientex Berhad (KLSE:SCIENTX) Suggests It's 30% Undervalued
Sep 23Scientex Berhad (KLSE:SCIENTX) Will Pay A Dividend Of MYR0.05
Sep 22Scientex Berhad (KLSE:SCIENTX) Is Paying Out A Larger Dividend Than Last Year
Jun 26Estimating The Fair Value Of Scientex Berhad (KLSE:SCIENTX)
May 11Scientex Berhad (KLSE:SCIENTX) May Have Issues Allocating Its Capital
Jan 27Scientex Berhad (KLSE:SCIENTX) Is Paying Out A Dividend Of MYR0.05
Dec 09Scientex Berhad (KLSE:SCIENTX) Has Affirmed Its Dividend Of MYR0.05
Oct 02Scientex Berhad (KLSE:SCIENTX) Shares Could Be 35% Below Their Intrinsic Value Estimate
Sep 23Here's Why Scientex Berhad (KLSE:SCIENTX) Can Manage Its Debt Responsibly
Sep 08Here's What's Concerning About Scientex Berhad's (KLSE:SCIENTX) Returns On Capital
Jul 13Here's Why I Think Scientex Berhad (KLSE:SCIENTX) Is An Interesting Stock
Apr 28Is There An Opportunity With Scientex Berhad's (KLSE:SCIENTX) 46% Undervaluation?
Mar 09These 4 Measures Indicate That Scientex Berhad (KLSE:SCIENTX) Is Using Debt Reasonably Well
Dec 09Calculating The Intrinsic Value Of Scientex Berhad (KLSE:SCIENTX)
Oct 21Return Trends At Scientex Berhad (KLSE:SCIENTX) Aren't Appealing
Sep 24I Built A List Of Growing Companies And Scientex Berhad (KLSE:SCIENTX) Made The Cut
Aug 21Does Scientex Berhad (KLSE:SCIENTX) Have A Healthy Balance Sheet?
Jun 08Is There An Opportunity With Scientex Berhad's (KLSE:SCIENTX) 28% Undervaluation?
May 26Scientex Berhad (KLSE:SCIENTX) Has Some Way To Go To Become A Multi-Bagger
May 11Scientex Berhad (KLSE:SCIENTX) Has A Rock Solid Balance Sheet
Mar 07Scientex Berhad's (KLSE:SCIENTX) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Feb 23Should We Be Excited About The Trends Of Returns At Scientex Berhad (KLSE:SCIENTX)?
Feb 09Are Investors Undervaluing Scientex Berhad (KLSE:SCIENTX) By 25%?
Jan 27
Here's What We Learned About The CEO Pay At Scientex Berhad (KLSE:SCIENTX)
Jan 15Scientex Berhad (KLSE:SCIENTX) Passed Our Checks, And It's About To Pay A RM0.13 Dividend
Dec 30Here's Why We Think Scientex Berhad (KLSE:SCIENTX) Is Well Worth Watching
Dec 29Scientex Berhad (KLSE:SCIENTX) Has Gifted Shareholders With A Fantastic 186% Total Return On Their Investment
Dec 18What Type Of Shareholders Own The Most Number of Scientex Berhad (KLSE:SCIENTX) Shares?
Dec 06Scientex Berhad (KLSE:SCIENTX) Has A Rock Solid Balance Sheet
Nov 24Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 7/31/2026 | 5,040 | 638 | N/A | 830 | 6 |
| 7/31/2025 | 4,780 | 593 | N/A | 806 | 7 |
| 7/31/2024 | 4,457 | 550 | N/A | 679 | 7 |
| 4/30/2024 | 4,379 | 524 | 755 | 863 | N/A |
| 1/31/2024 | 4,268 | 504 | 811 | 933 | N/A |
| 10/31/2023 | 4,154 | 469 | 789 | 895 | N/A |
| 7/31/2023 | 4,077 | 438 | 682 | 805 | N/A |
| 4/30/2023 | 4,117 | 448 | 653 | 775 | N/A |
| 1/31/2023 | 4,113 | 427 | 527 | 687 | N/A |
| 10/31/2022 | 4,087 | 414 | 498 | 678 | N/A |
| 7/31/2022 | 3,985 | 410 | 554 | 738 | N/A |
| 4/30/2022 | 3,844 | 428 | 501 | 691 | N/A |
| 1/31/2022 | 3,827 | 449 | 542 | 692 | N/A |
| 10/31/2021 | 3,782 | 468 | 585 | 737 | N/A |
| 7/31/2021 | 3,656 | 457 | 575 | 700 | N/A |
| 4/30/2021 | 3,640 | 457 | 600 | 718 | N/A |
| 1/31/2021 | 3,436 | 416 | 586 | 704 | N/A |
| 10/31/2020 | 3,443 | 402 | 575 | 679 | N/A |
| 7/31/2020 | 3,519 | 390 | 581 | 715 | N/A |
| 4/30/2020 | 3,503 | 381 | 584 | 712 | N/A |
| 1/31/2020 | 3,559 | 385 | 603 | 729 | N/A |
| 10/31/2019 | 3,411 | 361 | 545 | 661 | N/A |
| 7/31/2019 | 3,247 | 334 | 469 | 557 | N/A |
| 4/30/2019 | 3,029 | 283 | 341 | 414 | N/A |
| 1/31/2019 | 2,797 | 272 | 279 | 340 | N/A |
| 10/31/2018 | 2,661 | 266 | 282 | 358 | N/A |
| 7/31/2018 | 2,603 | 285 | 325 | 392 | N/A |
| 4/30/2018 | 2,528 | 274 | 379 | 456 | N/A |
| 1/31/2018 | 2,568 | 279 | N/A | 450 | N/A |
| 10/31/2017 | 2,523 | 276 | N/A | 377 | N/A |
| 7/31/2017 | 2,403 | 256 | N/A | 323 | N/A |
| 4/30/2017 | 2,318 | 238 | N/A | 329 | N/A |
| 1/31/2017 | 2,226 | 233 | N/A | 365 | N/A |
| 10/31/2016 | 2,185 | 232 | N/A | 353 | N/A |
| 7/31/2016 | 2,201 | 241 | N/A | 380 | N/A |
| 4/30/2016 | 2,092 | 236 | N/A | 326 | N/A |
| 1/31/2016 | 2,004 | 217 | N/A | 294 | N/A |
| 10/31/2015 | 1,921 | 189 | N/A | 254 | N/A |
| 7/31/2015 | 1,802 | 158 | N/A | 192 | N/A |
| 4/30/2015 | 1,765 | 158 | N/A | 157 | N/A |
| 1/31/2015 | 1,736 | 152 | N/A | 139 | N/A |
| 10/31/2014 | 1,657 | 149 | N/A | 142 | N/A |
| 7/31/2014 | 1,590 | 148 | N/A | 154 | N/A |
| 4/30/2014 | 1,546 | 130 | N/A | 171 | N/A |
| 1/31/2014 | 1,465 | 123 | N/A | 165 | N/A |
| 10/31/2013 | 1,352 | 115 | N/A | 189 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SCIENTX's forecast earnings growth (8.4% per year) is above the savings rate (3.6%).
Earnings vs Market: SCIENTX's earnings (8.4% per year) are forecast to grow slower than the MY market (11.8% per year).
High Growth Earnings: SCIENTX's earnings are forecast to grow, but not significantly.
Revenue vs Market: SCIENTX's revenue (6.4% per year) is forecast to grow faster than the MY market (6.2% per year).
High Growth Revenue: SCIENTX's revenue (6.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: SCIENTX's Return on Equity is forecast to be low in 3 years time (14.2%).